In the last few years, medications like tirzepatide have drawn...
Read MoreVials come unlabelled Batch Information: Â Certificate of Analysis (CoA)
Vials come unlabelled
Vials come unlabelled Batch Information: Â Certificate of Analysis (CoA)
Tirzepatide, Semaglutide and Retatrutide are peptides commonly discussed in relation to appetite signalling and metabolic processes.
Each interacts with the body in slightly different ways, offering varying levels of complexity and approach.
✓ Single-pathway Interaction (GLP-1)
✓ Steady and Consistent Effects
✓ Well-Established Peptide
✓ Dual-Pathway Interaction (GIP/GLP-1)
✓ Fullness and Appetite Signalling
✓ Next-Generation Peptide
✓ Triple-Pathway (GLP-1/GIP/Glucagon)
✓ Energy Use & Appetite Signalling
✓ Emerging Advanced Peptide
| Compound | Early Phase | Mid Phase | Higher Range | Notes |
|---|---|---|---|---|
| Tirzepatide | ~2.5 mg | ~5–10 mg | ~12.5–15 mg | Gradual escalation used in controlled trials. |
| Semaglutide | ~0.25 mg | ~0.5–1.0 mg | ~1.7–2.4 mg | Stepwise increases observed across studies. |
| Retatrutide | ~1–2 mg | ~4–6 mg | ~8–12 mg | Higher ranges linked to increased activity in trials. |
Dose ranges reflect published research observations only. Study protocols typically involve gradual escalation under controlled conditions.
Our platform is designed for all forms of GLP-1peptide research
TrimFast is a UK-based supplier specialising in research-grade peptides, including tirzepatide, semaglutide and retatrutide, for non-clinical use.
We support verified private researchers, laboratories, and qualified professionals with consistent, documented peptide materials designed for analytical and investigative work.
We are committed to providing reliable materials for scientific research, with a focus on quality, traceability, and compliance.
Research into GLP-1 and dual-agonist peptides continues to expand rapidly, with ongoing studies exploring:
TrimFast supports this evolving field by providing consistent, high-quality peptide materials for research environments.
Due to regulatory requirements, access is restricted to verified users.
Create an account to:
Register now for secure access to our UK research peptide supply.
If you’re unsure whether this applies to you, the FAQ below explains how access works and what our products can — and cannot — be used for.
Due to the ever growing compliancy laws, access to our store is restricted to verified account users only.
Verification requires:
Further details may include reviewing institutional details and professional credentials if required. (eg: name of academy, professional position…..)
Once registered, accounts are typically reviewed within 2 hours and you will receive an email to confirm access.
If you are rejected and believe it’s a mistake, please contact us at info@trimfast.online
We supply documented research-grade peptides, including Tirzepatide, Semaglutide & Retatrutide for approved non-clinical scientific investigation.
Research-grade refers to materials supplied with quality controls suitable for research. Materials are non-mixed, lyophilised (freeze dried) and vacuum sealed. Appropriate documentation is available for each batch.
No. Our materials are not intended for this and therefore should not be used for such. Materials should be used for research purposes only.
For questions related to verification or access requirements, please contact us at info@trimfast.online
In the last few years, medications like tirzepatide have drawn...
Read MoreWeight loss remains one of the most searched health topics...
Read MoreRetatrutide is an investigational peptide being developed by Eli Lilly...
Read MoreSemaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has...
Read More